Jason B. Daly, Executive Vice President, Chief Legal Officer, on August 11, 2026, sold 216,613 shares in Amneal Pharmaceuticals (AMRX) for $3,771,050. Following the Form 4 filing with the SEC, Daly has control over a total of 35,171 Class A common shares of the company, with 35,171 shares held directly.
SEC Filing: